These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 9849880)
1. Constitutive association of JAK1 and STAT5 in pro-B cells is dissolved by interleukin-4-induced tyrosine phosphorylation of both proteins. Erhardt I; Lischke A; Sebald W; Friedrich K FEBS Lett; 1998 Nov; 439(1-2):71-4. PubMed ID: 9849880 [TBL] [Abstract][Full Text] [Related]
2. The interleukin-4 receptor activates STAT5 by a mechanism that relies upon common gamma-chain. Lischke A; Moriggl R; Brändlein S; Berchtold S; Kammer W; Sebald W; Groner B; Liu X; Hennighausen L; Friedrich K J Biol Chem; 1998 Nov; 273(47):31222-9. PubMed ID: 9813029 [TBL] [Abstract][Full Text] [Related]
3. Activation of STAT5 by IL-4 relies on Janus kinase function but not on receptor tyrosine phosphorylation, and can contribute to both cell proliferation and gene regulation. Friedrich K; Kammer W; Erhardt I; Brändlein S; Sebald W; Moriggl R Int Immunol; 1999 Aug; 11(8):1283-94. PubMed ID: 10421786 [TBL] [Abstract][Full Text] [Related]
4. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Johnston JA; Bacon CM; Finbloom DS; Rees RC; Kaplan D; Shibuya K; Ortaldo JR; Gupta S; Chen YQ; Giri JD Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8705-9. PubMed ID: 7568001 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain. van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637 [TBL] [Abstract][Full Text] [Related]
6. SOCS-3 is tyrosine phosphorylated in response to interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation. Cohney SJ; Sanden D; Cacalano NA; Yoshimura A; Mui A; Migone TS; Johnston JA Mol Cell Biol; 1999 Jul; 19(7):4980-8. PubMed ID: 10373548 [TBL] [Abstract][Full Text] [Related]
7. Delineation of the regions of interleukin-2 (IL-2) receptor beta chain important for association of Jak1 and Jak3. Jak1-independent functional recruitment of Jak3 to Il-2Rbeta. Zhu MH; Berry JA; Russell SM; Leonard WJ J Biol Chem; 1998 Apr; 273(17):10719-25. PubMed ID: 9553136 [TBL] [Abstract][Full Text] [Related]
9. IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells. Rolling C; Treton D; Pellegrini S; Galanaud P; Richard Y FEBS Lett; 1996 Sep; 393(1):53-6. PubMed ID: 8804422 [TBL] [Abstract][Full Text] [Related]
10. Dispensability of Jak1 tyrosine kinase for interleukin-2-induced cell growth signaling in a human T cell line. Higuchi M; Asao H; Tanaka N; Oda K; Takeshita T; Nakamura M; Van Snick J; Sugamura K Eur J Immunol; 1996 Jun; 26(6):1322-7. PubMed ID: 8647212 [TBL] [Abstract][Full Text] [Related]
11. Adenosine acts through A2 receptors to inhibit IL-2-induced tyrosine phosphorylation of STAT5 in T lymphocytes: role of cyclic adenosine 3',5'-monophosphate and phosphatases. Zhang H; Conrad DM; Butler JJ; Zhao C; Blay J; Hoskin DW J Immunol; 2004 Jul; 173(2):932-44. PubMed ID: 15240680 [TBL] [Abstract][Full Text] [Related]
12. Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF beta-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases. Paukku K; Valgeirsdóttir S; Saharinen P; Bergman M; Heldin CH; Silvennoinen O Biochem J; 2000 Feb; 345 Pt 3(Pt 3):759-66. PubMed ID: 10642538 [TBL] [Abstract][Full Text] [Related]
13. Differential utilization of Janus kinase-signal transducer activator of transcription signaling pathways in the stimulation of human natural killer cells by IL-2, IL-12, and IFN-alpha. Yu CR; Lin JX; Fink DW; Akira S; Bloom ET; Yamauchi A J Immunol; 1996 Jul; 157(1):126-37. PubMed ID: 8683106 [TBL] [Abstract][Full Text] [Related]
14. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells. Kirken RA; Erwin RA; Wang L; Wang Y; Rui H; Farrar WL J Immunol; 2000 Nov; 165(9):5097-104. PubMed ID: 11046040 [TBL] [Abstract][Full Text] [Related]
15. Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways. Oakes SA; Candotti F; Johnston JA; Chen YQ; Ryan JJ; Taylor N; Liu X; Hennighausen L; Notarangelo LD; Paul WE; Blaese RM; O'Shea JJ Immunity; 1996 Dec; 5(6):605-15. PubMed ID: 8986719 [TBL] [Abstract][Full Text] [Related]
16. An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT. Fujitani Y; Hibi M; Fukada T; Takahashi-Tezuka M; Yoshida H; Yamaguchi T; Sugiyama K; Yamanaka Y; Nakajima K; Hirano T Oncogene; 1997 Feb; 14(7):751-61. PubMed ID: 9047382 [TBL] [Abstract][Full Text] [Related]
17. Convergence of signaling transduced by prolactin (PRL)/cytokine chimeric receptors on PRL-responsive gene transcription. Ferrag F; Chiarenza A; Goffin V; Kelly PA Mol Endocrinol; 1996 Apr; 10(4):451-60. PubMed ID: 8721989 [TBL] [Abstract][Full Text] [Related]
18. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. Carlesso N; Frank DA; Griffin JD J Exp Med; 1996 Mar; 183(3):811-20. PubMed ID: 8642285 [TBL] [Abstract][Full Text] [Related]
19. Critical proline residues of the cytoplasmic domain of the IL-5 receptor alpha chain and its function in IL-5-mediated activation of JAK kinase and STAT5. Kouro T; Kikuchi Y; Kanazawa H; Hirokawa K; Harada N; Shiiba M; Wakao H; Takaki S; Takatsu K Int Immunol; 1996 Feb; 8(2):237-45. PubMed ID: 8671609 [TBL] [Abstract][Full Text] [Related]
20. IL-13 induces phosphorylation and activation of JAK2 Janus kinase in human colon carcinoma cell lines: similarities between IL-4 and IL-13 signaling. Murata T; Noguchi PD; Puri RK J Immunol; 1996 Apr; 156(8):2972-8. PubMed ID: 8609418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]